174 related articles for article (PubMed ID: 31453359)
41. Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.
Papaioannou D; Rafia R; Rathbone J; Stevenson M; Buckley Woods H; Stevens J
Health Technol Assess; 2012; 16(37):1-253, iii-iv. PubMed ID: 23021127
[TBL] [Abstract][Full Text] [Related]
42. Growth and quality of the cost-utility literature, 1976-2001.
Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
[TBL] [Abstract][Full Text] [Related]
43. A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016.
Magnus A; Isaranuwatchai W; Mihalopoulos C; Brown V; Carter R
MDM Policy Pract; 2019; 4(1):2381468319852332. PubMed ID: 31192309
[No Abstract] [Full Text] [Related]
44. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A
Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561
[TBL] [Abstract][Full Text] [Related]
45. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
46. Measurement properties of instruments to assess pain in children and adolescents with cancer: a systematic review protocol.
Loeffen EAH; Stinson JN; Birnie KA; van Dijk M; Kulkarni K; Rijsdijk M; Font-Gonzalez A; Dupuis LL; van Dalen EC; Mulder RL; Campbell F; Tissing WJE; van de Wetering MD; Gibson F
Syst Rev; 2019 Jan; 8(1):33. PubMed ID: 30691495
[TBL] [Abstract][Full Text] [Related]
47. Exploring health state utility values of parents of children with a serious illness.
Majmudar IK; Engel L; Muscara F; Stevenson C; McCarthy M; Anderson V; Mihalopoulos C
Qual Life Res; 2020 Jul; 29(7):1947-1959. PubMed ID: 32335816
[TBL] [Abstract][Full Text] [Related]
48. Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling.
Brown J; Cook K; Adamski K; Lau J; Bargo D; Breen S; Chawla A
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):153-164. PubMed ID: 28335636
[TBL] [Abstract][Full Text] [Related]
49. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
[TBL] [Abstract][Full Text] [Related]
50. Clinical effectiveness and cost-effectiveness of stem cell transplantation in the management of acute leukaemia: a systematic review.
Ashfaq K; Yahaya I; Hyde C; Andronis L; Barton P; Bayliss S; Chen YF
Health Technol Assess; 2010 Dec; 14(54):iii-iv, ix-xi, 1-141. PubMed ID: 21138675
[TBL] [Abstract][Full Text] [Related]
51. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
52. Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.
Eddy K; Jordan Z; Stephenson M
JBI Database System Rev Implement Rep; 2016 Apr; 14(4):96-137. PubMed ID: 27532314
[TBL] [Abstract][Full Text] [Related]
53. Systematic reviews of health economic evaluations: a protocol for a systematic review of characteristics and methods applied.
Luhnen M; Prediger B; Neugebauer EAM; Mathes T
Syst Rev; 2017 Dec; 6(1):238. PubMed ID: 29197411
[TBL] [Abstract][Full Text] [Related]
54. Systematic review of health state utility values for economic evaluation of colorectal cancer.
Jeong K; Cairns J
Health Econ Rev; 2016 Dec; 6(1):36. PubMed ID: 27541298
[TBL] [Abstract][Full Text] [Related]
55. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.
Hendrix N; Kim DD; Patel KS; Devine B
Med Decis Making; 2021 Apr; 41(3):366-372. PubMed ID: 33451278
[TBL] [Abstract][Full Text] [Related]
56. Changes in Health State Utility Values in Japanese Patients with End-Stage Breast Cancer.
Iwatani T; Noto S; Tsugawa K
Curr Oncol; 2021 Oct; 28(5):4203-4212. PubMed ID: 34677274
[TBL] [Abstract][Full Text] [Related]
57. [Considerations on oncology at the Hospital of Miliana, utility of an anticancer secretariat].
SEROR J
Bull Alger Carcinol; 1948; 1(2):132-7. PubMed ID: 18869371
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
